中文名 | 1-Boc-4-羟基-4-(羟基甲基)-哌啶 |
---|---|
英文名 | tert-butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate |
中文别名 | 1-BOC-4-羟基-4-羟甲基哌啶 |
英文别名 |
RW2824
1-Piperidinecarboxylic acid, 4-hydroxy-4-(hydroxymethyl)-, 1,1-dimethylethyl ester t-butyl 4-hydroxy-4-(hydroxymethyl)tetrahydropyridine-1 (2H)-carboxylate 2-Methyl-2-propanyl 4-hydroxy-4-(hydroxymethyl)-1-piperidinecarboxylate 4-hydroxy-4-hydroxymethyl-piperidine-1-carboxylic acid tert-butyl ester 1-Boc-4-hydroxy-4-(hydroxymethyl)-piperidine |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 350.9±27.0 °C at 760 mmHg |
分子式 | C11H21NO4 |
分子量 | 231.289 |
闪点 | 166.0±23.7 °C |
精确质量 | 231.147064 |
PSA | 70.00000 |
LogP | 0.00 |
外观性状 | 白色至黄色固体 |
蒸汽压 | 0.0±1.7 mmHg at 25°C |
折射率 | 1.507 |
储存条件 | 2-8°C,密封,干燥 |
危害码 (欧洲) | Xi |
---|---|
海关编码 | 2933399090 |
~% 389889-80-9 |
文献:Ogino, Yoshio; Kurihara, Hideki; Matsuda, Kenji; Numazawa, Tomoshige; Otake, Norikazu; Noguchi, Kazuhito Patent: US2003/191316 A1, 2003 ; Location in patent: Page/Page column 36 ; |
~% 389889-80-9 |
文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; Location in patent: Page/Page column 197 ; |
~% 389889-80-9 |
文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
~% 389889-80-9 |
文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
~% 389889-80-9 |
文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
~% 389889-80-9 |
文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
上游产品 7 | |
---|---|
下游产品 0 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |